Reduced zinc in peripheral blood cells from patients with inflammatory connective tissue diseases.
By the use of the nuclear microprobe technique, the concentrations of zinc in isolated erythrocytes, platelets, and granulocytes were measured in patients with rheumatoid arthritis, other inflammatory arthritides, and scleroderma. Markedly reduced cellular zinc values were found compared to those measured in healthy subjects. No relation was found to inflammatory activity or disease duration. Plasma zinc was reduced in the majority of the patients and was negatively correlated to the inflammatory activity estimated by ESR and serum orosomucoid. No relation was found between total zinc values in plasma or cells or disease duration. Corticosteroid therapy was instituted in a number of the patients with inflammatory arthritides and induced a significant elevation of total zinc in all cell types, although normalization was not achieved. Plasma zinc values remained unchanged during the treatment.
D000328:Adult; D000368:Aged; D016918:Arthritis, Reactive / Q000097:blood; D001172:Arthritis, Rheumatoid / Q000097:blood; D001773:Blood Cells / Q000378:metabolism; D002118:Calcium / Q000097:blood; D003240:Connective Tissue Diseases / Q000097:blood*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood; D007501:Iron / Q000097:blood; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood; D013167:Spondylitis, Ankylosing / Q000097:blood; D015032:Zinc / Q000097:blood*
D007501:Iron; D015032:Zinc; D002118:Calcium